Dr. Matthew W. Ryan, MD

Dr. Ryan practices at University of Texas Southwestern Medical Center at Dallas in Dallas, Texas.

Dr. Ryan's NPI, 1487730271, was assigned on October 27, 2006. Dr. Ryan graduated from UTMB Health in 1996. Dr. Ryan holds Texas license L2617.

Dr. Ryan's primary practice is University of Texas Southwestern Medical Center at Dallas, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Ryan's primary practice is University of Texas Southwestern Medical Center at Dallas in Dallas, Texas. Dr. Ryan is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Ryan to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ryan practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Ryan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Ryan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Ryan's licenses on file in 3 states: Texas, South Carolina and Florida.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Ryan treats.

CMS data shows 476 Medicare services from Dr. Ryan across 7 procedure codes in 2024, for 225 Medicare patients. Medicare paid $60,763 for them.

CMS counts 225 Medicare patients who saw Dr. Ryan in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ryan's median patient age at 60, with 50% women.

In 2024, Dr. Ryan wrote 605 Medicare Part D claims for 191 patients. 98% of them were for generic drugs. CMS names the drug for 543 of them, across 11 drugs with 11 or more claims each, at $9,545 in total drug cost. In 2023, CMS named 475 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ryan for performance year 2024, reported as part of a group. Dr. Ryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ryan as offering telehealth.

Dmand AI links 45 papers to Dr. Ryan, published from 2007 to 2021. 2016 was the busiest year, with 5. The most frequent topics are Tomography, X-Ray Computed, Sinusitis and Allergens. Dr. Ryan has published most often in Int Forum Allergy Rhinol. Dr. Ryan's most frequent co-authors are Bradley Franklin Marple, MD, Ashleigh Anna Halderman, MD and Michael Peter Platt, MD.

CMS Open Payments shows 161 general payments to Dr. Ryan from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Sanofi and Genzyme US Companies paid the most, $89,643.

Dr. Ryan graduated from UTMB Health in 1996.

Dr. Ryan is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.